topsentin has been researched along with Adult Spinal Muscular Atrophy in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Artero, R; Berntenis, N; Chiriano, G; Comte, A; Ebeling, M; Faustino, I; Fournet, G; Garcia-Lopez, A; Goekjian, P; Hatje, K; Jonker, HRA; Joseph, B; Konieczny, P; Metzger, F; Orozco, M; Perozzo, R; Petermann, O; Richter, C; Scapozza, L; Schmucki, R; Schwalbe, H; Sciarra, D; Tessaro, F; Wacker, A | 1 |
1 other study(ies) available for topsentin and Adult Spinal Muscular Atrophy
Article | Year |
---|---|
Targeting RNA structure in SMN2 reverses spinal muscular atrophy molecular phenotypes.
Topics: Alternative Splicing; Animals; Animals, Genetically Modified; Drosophila; Drug Evaluation, Preclinical; Exons; HeLa Cells; Humans; Imidazoles; Indoles; Molecular Targeted Therapy; Muscular Atrophy, Spinal; Phenotype; Regulatory Elements, Transcriptional; RNA Splice Sites; RNA, Messenger; Survival of Motor Neuron 2 Protein | 2018 |